[go: up one dir, main page]

NO971495D0 - Svekkede virus og fremgangsmåte til deres fremstilling - Google Patents

Svekkede virus og fremgangsmåte til deres fremstilling

Info

Publication number
NO971495D0
NO971495D0 NO971495A NO971495A NO971495D0 NO 971495 D0 NO971495 D0 NO 971495D0 NO 971495 A NO971495 A NO 971495A NO 971495 A NO971495 A NO 971495A NO 971495 D0 NO971495 D0 NO 971495D0
Authority
NO
Norway
Prior art keywords
processes
preparation
attenuated viruses
attenuated
viruses
Prior art date
Application number
NO971495A
Other languages
English (en)
Other versions
NO971495L (no
Inventor
Jonathan W Nyce
Original Assignee
Univ East Carolina
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Univ East Carolina filed Critical Univ East Carolina
Publication of NO971495D0 publication Critical patent/NO971495D0/no
Publication of NO971495L publication Critical patent/NO971495L/no

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09Recombinant DNA-technology
    • C12N15/63Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
    • C12N15/79Vectors or expression systems specially adapted for eukaryotic hosts
    • C12N15/85Vectors or expression systems specially adapted for eukaryotic hosts for animal cells
    • C12N15/86Viral vectors
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00Medicinal preparations containing antigens or antibodies
    • A61K39/12Viral antigens
    • A61K39/21Retroviridae, e.g. equine infectious anemia virus
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00Drugs for immunological or allergic disorders
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N7/00Viruses; Bacteriophages; Compositions thereof; Preparation or purification thereof
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N7/00Viruses; Bacteriophages; Compositions thereof; Preparation or purification thereof
    • C12N7/04Inactivation or attenuation; Producing viral sub-units
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12QMEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/70Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving virus or bacteriophage
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12QMEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/70Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving virus or bacteriophage
    • C12Q1/701Specific hybridization probes
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12QMEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/70Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving virus or bacteriophage
    • C12Q1/701Specific hybridization probes
    • C12Q1/702Specific hybridization probes for retroviruses
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2740/00Reverse transcribing RNA viruses
    • C12N2740/00011Details
    • C12N2740/10011Retroviridae
    • C12N2740/16011Human Immunodeficiency Virus, HIV
    • C12N2740/16041Use of virus, viral particle or viral elements as a vector
    • C12N2740/16043Use of virus, viral particle or viral elements as a vector viral genome or elements thereof as genetic vector
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2740/00Reverse transcribing RNA viruses
    • C12N2740/00011Details
    • C12N2740/10011Retroviridae
    • C12N2740/16011Human Immunodeficiency Virus, HIV
    • C12N2740/16051Methods of production or purification of viral material

Landscapes

  • Life Sciences & Earth Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Genetics & Genomics (AREA)
  • Zoology (AREA)
  • Wood Science & Technology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Immunology (AREA)
  • Virology (AREA)
  • General Engineering & Computer Science (AREA)
  • Biotechnology (AREA)
  • General Health & Medical Sciences (AREA)
  • Microbiology (AREA)
  • Biochemistry (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Biomedical Technology (AREA)
  • Molecular Biology (AREA)
  • Physics & Mathematics (AREA)
  • Biophysics (AREA)
  • Medicinal Chemistry (AREA)
  • Analytical Chemistry (AREA)
  • Plant Pathology (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Communicable Diseases (AREA)
  • Hematology (AREA)
  • Mycology (AREA)
  • Epidemiology (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
NO971495A 1994-10-07 1997-04-02 Svekkede virus og fremgangsmåte til deres fremstilling NO971495L (no)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US08/319,974 US20030104576A1 (en) 1994-10-07 1994-10-07 Dna construct, composition, formulations & methods for making the construct & for modulating expression
PCT/US1995/013219 WO1996011280A1 (en) 1994-10-07 1995-10-05 Attenuated viruses and method of making the same

Publications (2)

Publication Number Publication Date
NO971495D0 true NO971495D0 (no) 1997-04-02
NO971495L NO971495L (no) 1997-05-26

Family

ID=23244339

Family Applications (1)

Application Number Title Priority Date Filing Date
NO971495A NO971495L (no) 1994-10-07 1997-04-02 Svekkede virus og fremgangsmåte til deres fremstilling

Country Status (10)

Country Link
US (1) US20030104576A1 (no)
EP (1) EP0784692A1 (no)
JP (1) JPH10507077A (no)
KR (1) KR970706399A (no)
CN (1) CN1169161A (no)
CA (1) CA2201487A1 (no)
MX (1) MX9702524A (no)
NO (1) NO971495L (no)
NZ (1) NZ295070A (no)
WO (1) WO1996011280A1 (no)

Families Citing this family (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6982253B2 (en) 2002-06-05 2006-01-03 Supergen, Inc. Liquid formulation of decitabine and use of the same
ES2322172T3 (es) * 2004-05-26 2009-06-17 Biovaxim Limited Composiciones que comprenden agentes desmetilantes como potenciadores de la inmunoterapia para el tratamiento de infecciones cronicas y enfermedades neoplasicas y metodos para tratar las mismas.
US7250416B2 (en) 2005-03-11 2007-07-31 Supergen, Inc. Azacytosine analogs and derivatives
US7700567B2 (en) 2005-09-29 2010-04-20 Supergen, Inc. Oligonucleotide analogues incorporating 5-aza-cytosine therein
CN101045946B (zh) * 2007-04-29 2010-09-29 深圳市疾病预防控制中心 Hiv基因检测芯片及其制备方法
AR063866A1 (es) * 2007-11-20 2009-02-25 Consejo Nac Invest Cient Tec Un procedimiento para la obtencion de cepas virales atenuadas
ES2573427T3 (es) 2009-07-06 2016-06-07 Variation Biotechnologies Inc. Procedimientos para preparar vesículas y formulaciones producidas a partir de las mismas
US9907746B2 (en) 2009-07-06 2018-03-06 Variation Biotechnologies, Inc. Methods for preparing vesicles and formulations produced therefrom
CA2862864C (en) * 2011-01-13 2018-12-11 Variation Biotechnologies Inc. Compositions and methods for treating viral infections
RU2605289C2 (ru) 2011-08-30 2016-12-20 Астекс Фармасьютикалз, Инк. Состав, набор и фармацевтическая композиция, содержащие производные децитабина, их получение и применение
EP2802353A4 (en) 2012-01-12 2015-12-02 Variation Biotechnologies Inc COMPOSITIONS AND METHOD FOR THE TREATMENT OF VIRUS INFECTIONS
US20150079077A1 (en) 2012-01-27 2015-03-19 Variation Biotechnologies, Inc. Methods and compositions for therapeutic agents
JP2018516594A (ja) * 2015-05-18 2018-06-28 カリミューン, インコーポレーティッド Hiv−1とレンチウイルスベクターとを識別する方法
WO2017004538A1 (en) 2015-07-02 2017-01-05 Otsuka Pharmaceutical Co., Ltd. Lyophilized pharmaceutical compositions
MX2020001233A (es) 2017-08-03 2020-07-20 Otsuka Pharma Co Ltd Compuesto farmaceutico y metodos de purificacion del mismo.
CN113186353A (zh) * 2021-05-28 2021-07-30 杭州晶佰生物技术有限公司 针对c型逆转录病毒的数字pcr检测用引物及检测方法

Also Published As

Publication number Publication date
NZ295070A (en) 1999-11-29
JPH10507077A (ja) 1998-07-14
AU3832795A (en) 1996-05-02
WO1996011280A1 (en) 1996-04-18
KR970706399A (ko) 1997-11-03
CN1169161A (zh) 1997-12-31
EP0784692A1 (en) 1997-07-23
US20030104576A1 (en) 2003-06-05
AU707782B2 (en) 1999-07-22
MX9702524A (es) 1998-02-28
NO971495L (no) 1997-05-26
CA2201487A1 (en) 1996-04-18

Similar Documents

Publication Publication Date Title
NO20004104D0 (no) Preparater omfattende virus og fremgangsmÕter for konsentrering av viruspreparater
FI20080432L (fi) L-nukleosidejä hepatiitti-B-viruksen ja Epstein-Barr-viruksen hoitamiseksi
NO971495L (no) Svekkede virus og fremgangsmåte til deres fremstilling
NO985196L (no) Dispergerbare makromolekylblandinger og fremgangsmÕter for deres fremstilli
NO922949D0 (no) Forbindelser og fremgangsmaater for inhibering av hiv- og beslektede virus
DK0909327T3 (da) Erythromyciner og fremgangsmåder til deres fremstilling
NO983965D0 (no) Polymer-organoleire-kompositter og deres fremstilling
FI971272A7 (fi) Heikennetty rokotus- ja geenisiirtovirus, menetelmä viruksen valmista miseksi ja virusta sisältävä farmaseuttinen koostumus
NO922275D0 (no) Aryletere, deres fremstilling og fremgangsmaate for behandling
AU7501898A (en) Live attenuated virus vaccines for equine encephalitis viruses
FI955224L (fi) Hepatiitti-C-virustyypit 4,5 ja 6
MX9202781A (es) Vacuna y metodo de tratamiento para virus de inmunodeficiencia humana.
FI964605L (fi) Hepatiitti-G virus ja sen molekyylikloonaus
DK0991666T3 (da) Alfa-1-antitrypsin-præparat og fremgangsmåde til fremstilling heraf
DK1001684T3 (da) Afvandede kartoffelstykker og fremgangsmåde til deres fremstilling
NO943794L (no) 4-difenylmethylpiperidinderivater, og fremgangsmåte for deres fremstilling
IS5777A (is) Bóluefnisvakið lifrarbólgu B veiruafbrigði og notkun þess
NO941517L (no) 2-amino-4-kinolin-dihydropyridiner, fremgangsmåter for deres fremstilling og deres anvendelse
NO931246D0 (no) Sammensetninger for behandling av infeksjon og sykdom foraarsaket av hepatites b virus (hbv)
FI953952L (fi) Lämmönkestäviä polarisaattoreita
DK384387D0 (da) Erythromycin-derivater til forebyggelse og behandling af sygdomme fremkaldt af virus
BR9506962A (pt) Cultura seletiva de virus
DK70793D0 (da) Fjernvarmeroerstraekning og fremgangsmaade til preparering deraf
DE69824881D1 (de) Kompakte replikons des epstein-barr-virus.
PT841943E (pt) Virus herpeticos avirulentos uteis como agentes tumoricidas e vacinas

Legal Events

Date Code Title Description
FC2A Withdrawal, rejection or dismissal of laid open patent application